Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee approves bill restricting manufacturer limits on 340B contract pharmacies after split testimony
Summary
House Bill 1242, which would limit drug manufacturers’ ability to restrict 340B contract‑pharmacy arrangements and curb excessive data demands, cleared the Insurance Committee 16-1-1 following testimony from pharmaceutical industry and safety‑net provider representatives.
The House Insurance Committee on March 25 voted 16-1 with one present-not-voting to advance House Bill 1242 to the Finance, Ways and Means Committee. The bill would protect 340B covered entities by barring pharmaceutical manufacturers from interfering with contract pharmacy arrangements and from trying to shift the program from upfront discounts to post‑sale rebate models, measures proponents say preserve access and financial stability for safety‑net providers.
Madam Chair Liddy and other committee leaders described the bill as clarifying and protective of safety‑net access. The bill’s sponsor explained the amended measure by referencing the…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
